Celmatix and Aché Laboratórios Announce Collaboration to Investigate a Novel Melatonin Receptor Agonists for Women’s Health

Previous
Previous

Celmatix Nominates First Lead Compound in Oral Fertility Drug Program

Next
Next

Celmatix Announces Breakthrough in Novel Oral Fertility Drug Program